Center-Authored Papers

Filters: Author is Khorana, Alok A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
V
Lyman GH, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW, Gates LE et al..  2013.  Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(17):2189-204. Abstract
Lyman GH, Bohlke K, Khorana AA, Kuderer NM, Lee AY, Arcelus JI, Balaban EP, Clarke JM, Flowers CR, Francis CW et al..  2015.  Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(6):654-6. Abstract
Khorana AA, Streiff MB, Farge D, Mandala M, Debourdeau P, Cajfinger F, Marty M, Falanga A, Lyman GH.  2009.  Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(29):4919-26. Abstract
Komrokji RS, Uppal NP, Khorana AA, Lyman GH, Kaplan KL, Fisher RI, Francis CW.  2006.  Venous thromboembolism in patients with diffuse large B-cell lymphoma.. Leukemia & lymphoma. 47(6):1029-33. Abstract
Ferro SA, Myer BS, Wolff DA, Poniewierski MS, Culakova E, Cosler LE, Scarpace SL, Khorana AA, Lyman GH.  2008.  Variation in the cost of medications for the treatment of colorectal cancer.. The American journal of managed care. 14(11):717-25. Abstract
Kuderer NM, Culakova E, Lyman GH, Francis C, Falanga A, Khorana AA.  2016.  A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality.. The oncologist. Abstract
T
Lyman GH, Khorana AA, Falanga A.  2013.  Thrombosis and cancer.. American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting. :337-45. Abstract
Khorana AA, Francis CW, Culakova E, Fisher RI, Kuderer NM, Lyman GH.  2006.  Thromboembolism in hospitalized neutropenic cancer patients.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 24(3):484-90. Abstract
R
Khorana AA, Francis CW, Culakova E, Lyman GH.  2005.  Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.. Cancer. 104(12):2822-9. Abstract
Lyman GH, Khorana AA, Kuderer N, Prestrud AA, Falanga A.  2013.  Reply to T.H. Oo.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(34):4381-2.
P
Khorana AA, Spyropoulos AC, Zwicker J, Lyman GH, Francis CW.  2012.  Preventing VTE in Outpatients With Cancer.. Chest. 142(1):265-6;authorreply266-7.
Philip PA, Benedetti JK, Corless CL, Wong R, O'Reilly EM, Flynn PJ, Rowland KM, Atkins JN, Mirtsching BC, Rivkin SE et al..  2010.  Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(22):3605-10. Abstract
M
Kuderer NM, Khorana AA, Lyman GH, Francis CW.  2007.  A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications.. Cancer. 110(5):1149-61. Abstract
L
Connolly GC, Khorana AA, Kuderer NM, Culakova E, Francis CW, Lyman GH.  2010.  Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy.. Thrombosis research. 126(2):113-8. Abstract
I
Somerfield MR, Bohlke K, Browman GP, Denduluri N, Einhaus K, Hayes DF, Khorana AA, Miller RS, Mohile SG, Oliver TK et al..  2016.  Innovations in American Society of Clinical Oncology Practice Guideline Development.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
F
Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH.  2007.  Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients.. Cancer. 110(10):2339-46. Abstract
D
Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW.  2008.  Development and validation of a predictive model for chemotherapy-associated thrombosis.. Blood. 111(10):4902-7. Abstract
Khorana AA, Francis CW, Kuderer NM, Carrier M, Ortel TL, Wun T, Rubens D, Hobbs S, Iyer R, Peterson D et al..  2017.  Dalteparin thromboprophylaxis in cancer patients at high risk for venous thromboembolism: A randomized trial.. Thrombosis research. Abstract
C
Lyman GH, Khorana AA.  2009.  Cancer, clots and consensus: new understanding of an old problem.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(29):4821-6.
Lyman GH, Khorana AA, Kuderer NM, Lee AY.  2009.  Cancer and thrombosis: back to the future renewed interest in an old problem.. Cancer investigation. 27(5):472-3. Abstract
B
Khorana AA, Francis CW, Blumberg N, Culakova E, Refaai MA, Lyman GH.  2008.  Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer.. Archives of internal medicine. 168(21):2377-81. Abstract
A
Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, Jahanzeb M, Kakkar A, Kuderer NM, Levine MN, Liebman H et al..  2007.  American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(34):5490-505. Abstract